A Market-Based Mechanism for Global Vaccine Procurement Coalitions

Problem definition: Equitable vaccine distribution is paramount to containing global disease outbreaks. An important pathway to achieve this goal is pooled vaccine procurement through global coalitions, exemplified by the COVID-19 Vaccine Global Access (COVAX) initiative, which was implemented based on equitable, centrally managed vaccine allocation, affordable prices, and subsidies to fund lower-income economies. However, the limited participation of high-income countries—which chose to purchase vaccines directly from manufacturers via bilateral agreements—reduced the supply available to COVAX and compromised the equity objective of the initiative. Regulatory barriers, such as export bans, exacerbated the coalition’s lack of access to vaccines. In this paper, we propose a market-based mechanism to enhance participation in a global vaccine procurement coalition under supply constraints. Methodology/results: We develop a new variant of the Fisher market model by incorporating a Nash bargaining game that captures bilateral agreement negotiation under regulation. We show that adopting market-clearing prices to match vaccine supply with demand in the coalition can effectively discourage bilateral agreements, provided that countries do not impose stringent export restrictions or possess dominating negotiation power. Complementing market-clearing prices with a subsidy allocation that accounts for disparities in risk, per-capita procurement budget, and power across countries can lead to an equitable vaccine distribution outcome, if sufficient subsidy funding is available. A case study based on COVAX illustrates the equity improvements of the proposed mechanism under practical settings. Managerial implications: Achieving vaccine equity in health emergencies marked by supply constraints may require an integrated approach that combines market mechanisms to incentivize global participation with centrally coordinated aid to address disparities in wealth and power. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2025.0036 .

Authors

Institutions

Publication Details

Journal
Manufacturing & Service Operations Management
Published
2025-10-31
DOI
https://doi.org/10.1287/msom.2025.0036
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Market-Based Mechanism for Global Vaccine Procurement Coalitions

Luyi Gui
Manufacturing & Service Operations Management
Vaccine Coverage and Hesitancy
article

A Market-Based Mechanism for Global Vaccine Procurement Coalitions

Luyi Gui
article en

Abstract

Problem definition: Equitable vaccine distribution is paramount to containing global disease outbreaks. An important pathway to achieve this goal is pooled vaccine procurement through global coalitions, exemplified by the COVID-19 Vaccine Global Access (COVAX) initiative, which was implemented based on equitable, centrally managed vaccine allocation, affordable prices, and subsidies to fund lower-income economies. However, the limited participation of high-income countries—which chose to purchase vaccines directly from manufacturers via bilateral agreements—reduced the supply available to COVAX and compromised the equity objective of the initiative. Regulatory barriers, such as export bans, exacerbated the coalition’s lack of access to vaccines. In this paper, we propose a market-based mechanism to enhance participation in a global vaccine procurement coalition under supply constraints. Methodology/results: We develop a new variant of the Fisher market model by incorporating a Nash bargaining game that captures bilateral agreement negotiation under regulation. We show that adopting market-clearing prices to match vaccine supply with demand in the coalition can effectively discourage bilateral agreements, provided that countries do not impose stringent export restrictions or possess dominating negotiation power. Complementing market-clearing prices with a subsidy allocation that accounts for disparities in risk, per-capita procurement budget, and power across countries can lead to an equitable vaccine distribution outcome, if sufficient subsidy funding is available. A case study based on COVAX illustrates the equity improvements of the proposed mechanism under practical settings. Managerial implications: Achieving vaccine equity in health emergencies marked by supply constraints may require an integrated approach that combines market mechanisms to incentivize global participation with centrally coordinated aid to address disparities in wealth and power. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2025.0036 .

Manufacturing & Service Operations ManagementVol. 28(1)
University of California, Irvine (US), University of California System (US)
Openalex Percentile: Top 60%
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.